troleandomycin has been researched along with mk 0591 in 1 studies
| Studies (troleandomycin) | Trials (troleandomycin) | Recent Studies (post-2010) (troleandomycin) | Studies (mk 0591) | Trials (mk 0591) | Recent Studies (post-2010) (mk 0591) |
|---|---|---|---|---|---|
| 569 | 26 | 23 | 64 | 6 | 17 |
| Protein | Taxonomy | troleandomycin (IC50) | mk 0591 (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 2.6029 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 4.0003 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.011 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.2503 | |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | 0.0086 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arruda, JM; Baccei, C; Bain, G; Chapman, C; Correa, L; Darlington, J; Evans, JF; Hutchinson, JH; King, CD; Lee, C; Li, Y; Lorrain, D; Prasit, P; Prodanovich, P; Rong, H; Santini, A; Stock, N | 1 |
1 other study(ies) available for troleandomycin and mk 0591
| Article | Year |
|---|---|
5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103).
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Asthma; Carrier Proteins; Dogs; Drug-Related Side Effects and Adverse Reactions; Heterocyclic Compounds; Humans; Indoles; Inhibitory Concentration 50; Leukotriene B4; Membrane Proteins; Mice; Propionates; Protein Binding; Rats; Structure-Activity Relationship | 2009 |